What are the treatment options for migraine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Treatment

For acute migraine, start with NSAIDs (aspirin, ibuprofen, naproxen, or diclofenac) for mild-to-moderate attacks, and escalate to triptans for moderate-to-severe attacks or when NSAIDs fail—combining a triptan with an NSAID provides superior efficacy to either agent alone. 1, 2

Acute Treatment Algorithm

Mild-to-Moderate Attacks

  • First-line: NSAIDs with proven efficacy include aspirin, ibuprofen, naproxen sodium, and diclofenac potassium 1, 3
  • Paracetamol (acetaminophen) has inferior efficacy and should only be used when NSAIDs are contraindicated 1
  • Combination analgesics containing caffeine (aspirin + acetaminophen + caffeine) can be effective for mild attacks 1, 2
  • Dosing example for naproxen: 500-825 mg at onset, repeat every 2-6 hours as needed (maximum 1.5 g/day) 2

Moderate-to-Severe Attacks

  • First-line: Triptans, with or without NSAIDs 1, 2, 3
  • Critical timing principle: Administer triptans early in the attack while headache is still mild for maximum effectiveness 1, 3
  • Combination therapy: Triptan + NSAID provides synergistic benefit superior to either agent alone 1, 3
  • Oral triptan options with strong evidence: sumatriptan 50-100 mg, rizatriptan, naratriptan, zolmitriptan 2
  • If one triptan fails, try a different triptan—failure of one does not predict failure of others 1, 2

Non-Oral Routes for Nausea/Vomiting

  • Subcutaneous sumatriptan 6 mg provides highest efficacy (59% pain-free at 2 hours) but with higher adverse event rates 2
  • Intranasal sumatriptan 5-20 mg or nasal spray triptans 2
  • Intranasal dihydroergotamine (DHE) has good evidence for efficacy and safety 2

Managing Associated Symptoms

  • Antiemetics (metoclopramide 10 mg IV or prochlorperazine 10 mg IV) provide synergistic analgesia beyond treating nausea alone 1, 2
  • Add antiemetic 20-30 minutes before NSAID for improved outcomes 2

Advanced/Rescue Treatment Options

Third-Line Agents (When Triptans Fail or Are Contraindicated)

  • CGRP antagonists (gepants): rimegepant, ubrogepant, or zavegepant 1
  • Lasmiditan (ditan) 1
  • Dihydroergotamine (DHE) 1, 2

Intravenous Treatment for Severe Attacks

  • Preferred IV combination: Metoclopramide 10 mg IV + ketorolac 30 mg IV provides rapid relief with minimal rebound risk 2
  • Prochlorperazine 10 mg IV is comparable to metoclopramide in efficacy 2
  • Ketorolac has 6-hour duration with minimal medication overuse headache risk 2

Critical Pitfalls to Avoid

Medication Overuse Headache (MOH)

  • Limit acute medication use: ≤15 days/month for NSAIDs, ≤10 days/month for triptans 1
  • Avoid entirely: Opioids and butalbital-containing analgesics—these lead to dependency, rebound headaches, and loss of efficacy 1, 2
  • If using acute medications >2 days/week, transition to preventive therapy 2, 3

Triptan Safety Considerations

  • Contraindicated in: coronary artery disease, Prinzmetal's angina, uncontrolled hypertension, history of stroke/TIA, Wolff-Parkinson-White syndrome 4
  • Monitor for chest/throat/neck/jaw tightness—perform cardiac evaluation if high cardiac risk 4
  • Risk of serotonin syndrome when combined with SSRIs, SNRIs, TCAs, or MAO inhibitors 4

Preventive Treatment Indications

Consider preventive therapy when: 1, 3

  • ≥2 attacks per month producing disability lasting ≥3 days/month
  • Contraindication to or failure of acute treatments
  • Acute medication use >2 days/week
  • Presence of uncommon migraine conditions (hemiplegic migraine, prolonged aura)

First-Line Preventive Options

  • Beta-blockers, topiramate (discuss teratogenic effects with women of childbearing potential), or candesartan 1, 3
  • ACE inhibitors, ARBs, or SSRIs if first-line agents not tolerated 1
  • Start at low dose and titrate gradually; allow 2-3 months for oral agents to demonstrate efficacy 2

Lifestyle Modifications

Essential non-pharmacologic interventions: 1, 3

  • Maintain regular meal schedule and adequate hydration
  • Ensure consistent sleep schedule with sufficient sleep duration
  • Engage in regular moderate-to-intense aerobic exercise
  • Implement stress management (relaxation techniques, mindfulness, cognitive-behavioral therapy)

Monitoring Strategy

  • Headache diary: Track severity, frequency, duration, disability, treatment response, and adverse effects 3
  • Use diary to identify medication overuse patterns and assess treatment efficacy 1, 3
  • Switch preventive treatment if inadequate response after reasonable trial period 1

References

Guideline

Migraine Treatment Strategies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Migraine Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.